Tuesday, September 10, 2024 | 1:00–2:00 PM EDT | Virtual
Contact Hours: 1.0
Target Audience: Students, Residents, Fellows, Pharmacists
UAN: 0217-9999-24-186-L01-P
Activity Type: Application
Fees & Registration
Cardiology/Critical Care PRN Members: $0.00
ACCP Members: $10.00
Non-ACCP Members: $20.00
|
Register Now |
Description:
The past decade of research in patients with heart failure has seen many therapeutic advances. A majority of this research has focused on optimization of pharmacotherapy in patients stable for hospital discharge or those in the community setting. Management and initiation of guideline-directed medical therapy (GDMT) for critically ill patients with heart failure in the intensive care unit is less well characterized and much of the recommendations are extrapolated from the outpatient setting or expert recommendations. There is a growing body of literature on how to best optimize pharmacotherapies while patients are critically ill. However, a uniform consensus on optimization in the acute setting is lacking. Less evidence is available to best guide the management of acute right ventricle failure. Decongestion strategies continue to evolve and new information continues to guide decongestive strategies beyond loop diuretics.
This program looks to characterize evidence-based pharmacotherapy in critically ill patients with heart failure with reduced ejection fraction (HFrEF), acute right ventricular failure, and/or diuretic resistance.
Learning Objectives:
- Interpret clinical criteria to differentiate between left and right heart failure
- Assess current evidence for implementation of guideline-directed medical therapy (GDMT) in the ICU
- Develop a pharmacotherapy plan to overcome acute right heart failure
- Differentiate the use of diuretic strategies to overcome diuretic resistance
Moderator:
Jack Pluenneke, Pharm.D., BCCP
Clinical Pharmacy Specialist
Saint Luke's Hospital
Kansas City, Missouri
Speakers:
Joseph S. Van Tuyl, Pharm.D., BCCP
Associate Professor
Department of Pharmacy Practice
St. Louis College of Pharmacy at UHSP
St. Louis, Missouri
Payal K. Gurnani, Pharm.D., BCPS, BCCCP, FCCM
Clinical Pharmacy Specialist
Surgical-Liver Intensive Care Unit
Department of Pharmacy
Houston Methodist Hospital, Houston, Texas
Technical Requirements
This webinar will be conducted on Zoom. View Zoom System Requirements.
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To obtain your CPE credit after the event, please visit www.accp.com, sign in, and complete the attestation statement related to this activity. You must claim your CPE by November 9, 2024. Statements of credit will be available via CPE Monitor within 2–3 business days of claiming credit. ACCP cannot issue CPE credit to any participant who does not have a date of birth and NABP e-Profile ID number on file with ACCP. Credit will not be awarded after November 9, 2024.